Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when the implant is placed within an animal.

 
Web www.patentalert.com

< Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases

< Electrical devices and anti-scarring agents

> SYSTEM AND METHOD FOR PROCESSING ANALYTE SENSOR DATA

> Lysyl oxidase-like 1 (LOXL1) and elastogenesis

~ 00203